Barclays Starts Vertex (VRTX) at Equalweight

Go back to Barclays Starts Vertex (VRTX) at Equalweight

BTIG Starts Vertex (VRTX) at Buy

January 5, 2015 5:34 PM EST

BTIG initiated coverage on Vertex (NASDAQ: VRTX) with a Buy rating and a price target of $200.00.

Analyst Hartaj Singh said, "We believe that current valuation is not indicative of the significant potential for combination Kalydeco/lumacaftor therapy in cystic fibrosis. We are... More